The NCRS team attended an international medical forum in Minsk
19.04.2025
Domestic Reference Standards: The Foundation of Pharmaceutical Quality Control and Industry Sovereignty
08.05.2025
Annual Reporting Meeting with the Founder of FSI "SID and GP":
Andrey Berman Summarizes 2024 Results
Andrey Arkadievich Berman, General Director of NCRS, presented the company's annual performance report for 2024. In his address, he highlighted key achievements and development strategies, emphasizing production volume increases and project scaling.
The annual results exceeded even the most ambitious expectations – the team achieved a fivefold sales growth. This impressive outcome was made possible through expansion of developed reference materials and exceptional team coordination.
The implementation of a Quality Management System (QMS) and obtaining GMP certification enabled NCRS to broaden its range of laboratory services. The company has now secured major contracts for reference standard development and pharmaceutical testing.
2024 marked a year of significant accomplishments for NCRS. The key growth driver was forming strategic partnerships with pharmaceutical market leaders. These contracts not substantially boosted sales but also reinforced the company's reputation as a reliable pharmaceutical industry partner.
Andrey Berman emphasized that these results demonstrate the company's correct strategic direction. For commercial operations, NCRS plans to maintain momentum in product sales growth and expansion of laboratory services.
